Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
NCT02144610
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Critical Limb Ischemia
Interventions
BIOLOGICAL:
HGF Plasmid (AMG0001)
BIOLOGICAL:
Matching Placebo
Sponsor
AnGes USA, Inc.